Fmoc-D-Asp-OtBu

Fmoc-D-Asp-OtBu is a protected, non-natural stereochemical form of aspartic acid in which the α-amino group is carbamated with an Fmoc protecting group and the α-carboxyl group is esterified as a tert-butyl ester (OtBu), yielding a stepwise peptide synthesis intermediate. The side chain retains the β-carboxylic acid functionality characteristic of Asp, and the molecule bears the D stereochemical configuration as indicated by the product name while presenting no free amino or free carboxyl groups at the α-position. Fmoc-D-Asp-OtBu is used in solid-phase or solution-phase peptide assembly where Fmoc provides orthogonal protection for controlled deprotection and the OtBu ester helps suppress undesired carboxyl reactivity during coupling steps, while the β-carboxyl group can be addressed in subsequent derivatization or peptide design.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP25321

CAS No:134098-70-7

Synonyms/Alias:fmoc-d-asp-otbu;Fmoc-D-Asparticacid1-tert-butylester;134098-70-7;AmbotzFAA1311;SCHEMBL7423417;CTK8C5185;MolPort-006-705-565;ACT10803;ZINC2560715;ANW-74498;CF-781;AJ-40630;AK-49702;AN-32013;TR-004617;FT-0658408;FT-0679697;FT-0686518;FT-0688452;ST24047248;J-300079;Q-101784;(3R)-4-(tert-butoxy)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-oxobutanoicacid;(3R)-4-tert-butoxy-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxo-butanoicacid;(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoicacid

Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-aspartic acid alpha-t-butyl ester

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C23H25NO6
M.W/Mr.
411,46 g/mole

Fmoc-D-Asp-OtBu is a stereochemically defined, N-(9H-fluoren-9-ylmethoxycarbonyl) protected D-aspartic acid tert-butyl ester that functions as a protected amino acid building block for peptide synthesis. The molecule contains the D-configured α-amino stereocenter and a side-chain carboxyl group masked as a tert-butyl ester, while the Fmoc carbamate protects the α-amine during coupling and can be removed under base to expose the amine for sequential chain assembly. The orthogonal protection pattern (base-labile Fmoc and acid-labile tert-butyl ester) yields a predictable reactivity profile, with the side-chain carboxyl remaining non-nucleophilic until deprotection. The presence of a chiral center, a protected carboxyl functionality, and a stable aromatic Fmoc group makes Fmoc-D-Asp-OtBu suitable for controlled peptide construction, as well as downstream conversion into selectively functionalized D-aspartate derivatives.

1. Peptide Synthesis

Fmoc-D-Asp-OtBu supports solid-phase peptide synthesis workflows where orthogonal protection is required for aspartate incorporation. The Fmoc-protected D-α-amine enables standard peptide coupling after base-mediated Fmoc removal, while the tert-butyl ester on the side-chain carboxyl suppresses undesired side reactions during chain elongation. The D stereochemistry can be leveraged to prepare D-Asp-containing peptides for stereochemical probing, protease resistance studies, and backbone engineering. Side-chain deprotection can later regenerate the free carboxyl for intramolecular salt-bridge formation, metal coordination, or further derivatization, aligning the building block with peptide analog construction and amino acid chemistry strategies.

2. Side-Chain Functionalization

Fmoc-D-Asp-OtBu is applicable to amino acid derivatization programs that require controlled activation of the side-chain carboxyl group. The tert-butyl ester protects the aspartate side chain during manipulations that target the α-amino functionality through Fmoc chemistry, enabling sequential functional group transformations without premature carboxyl exposure. After deprotection, the regenerated carboxyl can be converted into amides, esters, activated acyl intermediates, or conjugation handles for downstream chemical biology and materials-oriented scaffolds. The chiral D-aspartate framework further supports stereodefined ligand or peptidomimetic synthesis where stereochemical fidelity of the amino acid side chain influences binding and reactivity outcomes.

3. Peptidomimetics And SAR

Fmoc-D-Asp-OtBu can be employed in peptidomimetic construction and structure-activity relationship studies requiring incorporation of D-aspartate residues into constrained analogs. The protected carboxyl and Fmoc-protected amine allow stepwise assembly of D-Asp-containing fragments that can be cyclized, modified, or used as stereochemical probes in SAR workflows. The orthogonal deprotection logic enables selective unveiling of the side-chain carboxyl for forming amide linkages or for introducing negatively charged functionalities that mimic native aspartate behavior. The resulting D-aspartate-containing intermediates can be carried into fragment elaboration and analog libraries where peptide coupling compatibility and controlled functional group presentation are central to systematic structure exploration.

4. Chemical Manufacturing Intermediates

Fmoc-D-Asp-OtBu is suitable for industrial chemical manufacturing routes that require protected amino acid intermediates for fine chemical synthesis. The Fmoc carbamate and tert-butyl ester provide a robust, isolable protection scheme that can be integrated into process chemistry intermediate preparation, including controlled deprotection steps to generate reactive amine and carboxyl functionalities on demand. The defined D configuration supports stereoselective manufacturing of chiral building blocks used in peptide fragment production and downstream derivatization streams. The compound's protected functional groups can be employed to standardize intermediate handling, reduce side reactions during coupling steps, and enable scalable production of D-aspartate-containing derivatives for research and specialty chemical applications.

5. Analytical Standards And Labeling

Fmoc-D-Asp-OtBu can serve in analytical research contexts where stereodefined aspartate-containing standards or derivatization substrates are required. The combination of Fmoc and a protected side-chain carboxyl allows controlled conversion into detectable derivatives after deprotection, supporting method development for monitoring D-aspartate incorporation, peptide fragment integrity, or carboxyl functional group transformations. The stable aromatic Fmoc handle may also facilitate chromatographic behavior differences compared with unprotected amino acids, aiding separation in peptide and amino acid analyses. The chiral D-aspartate scaffold can be adapted into labeling and reference material preparation workflows that support quality control of peptide building blocks and stereochemical composition in biochemical research pipelines.

Size
1 g;5 g;
InChI
1S/C23H25NO6/c1-23(2,3)30-21(27)19(12-20(25)26)24-22(28)29-13-18-16-10-6-4-8-14(16)15-9-5-7-11-17(15)18/h4-11,18-19H,12-13H2,1-3H3,(H,24,28)(H,25,26)/t19-/m1/s1
InChI Key
VZXQYACYLGRQJU-LJQANCHMSA-N
Canonical SMILES
CC(C)(C)OC(=O)C(CC(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicescGMP Peptide ServiceCustom Conjugation ServicePeptide Modification ServicesPeptide CDMOPeptide Nucleic Acids SynthesisPeptide Analysis ServicesEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers